Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $254,127 - $389,437
18,741 New
18,741 $270,000
Q2 2023

Aug 14, 2023

SELL
$22.62 - $39.32 $131,784 - $229,078
-5,826 Reduced 24.35%
18,100 $460,000
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $196,557 - $267,831
6,515 Added 37.42%
23,926 $864,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $634,282 - $860,103
17,411 New
17,411 $689,000
Q3 2021

Nov 16, 2021

SELL
$101.99 - $166.36 $2.19 Million - $3.57 Million
-21,449 Closed
0 $0
Q2 2021

Nov 16, 2021

SELL
$141.6 - $179.06 $141,600 - $179,060
-1,000 Reduced 4.45%
21,449 $3.56 Million
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $3.18 Million - $4.02 Million
22,449 New
22,449 $3.72 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $446,444 - $648,081
-4,991 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $201,911 - $414,891
2,875 Added 135.87%
4,991 $499,000
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $161,683 - $248,714
2,116 New
2,116 $248,000
Q4 2018

Feb 14, 2019

SELL
$35.43 - $56.29 $216,123 - $343,369
-6,100 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $48,642 - $83,017
1,100 Added 22.0%
6,100 $348,000
Q2 2018

Aug 14, 2018

SELL
$72.38 - $92.5 $1.09 Million - $1.39 Million
-15,008 Reduced 75.01%
5,000 $399,000
Q1 2018

May 15, 2018

SELL
$69.46 - $88.57 $1.84 Million - $2.35 Million
-26,547 Reduced 57.02%
20,008 $1.73 Million
Q4 2017

Feb 14, 2018

BUY
$65.94 - $93.31 $2.84 Million - $4.01 Million
42,995 Added 1207.72%
46,555 $3.21 Million
Q3 2017

Nov 14, 2017

BUY
$80.87 - $91.08 $287,897 - $324,244
3,560
3,560 $324,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.